NCT07502196Not yet recruiting
Heart Problems in Children With Chronic Liver Disease
Assessment of Cardiac Problems in Children With Chronic Liver Disease
Source: ClinicalTrials.gov · Last updated 30 Mar 2026
Brief summary (registry, in English)
Chronic liver disease (CLD) in children can sometimes lead to complications in other parts of the body, including the heart. The primary purpose of this observational study is to assess the presence and type of cardiac problems in children who have been diagnosed with chronic liver disease. Researchers will observe children under the age of 18 who are receiving care at the gastroenterology and hepatology unit at Assiut University Children Hospital. Participants will undergo standard medical evaluations to check both their liver and heart health. These evaluations include: * A detailed medical history and thorough physical examination * Routine blood tests to check liver function, kidney function, coagulation, and electrolytes * Abdominal imaging, such as an ultrasound, to look at the liver. * An electrocardiogram (ECG) to check the heart's electrical activity and rhythm, including measuring the QTc interval. * An echocardiogram to look at the structure of the heart and check how well its chambers and valves are functioning. The study aims to identify specific heart conditions that can be associated with severe liver disease, such as portopulmonary hypertension, cirrhotic cardiomyopathy (changes in the heart muscle's function), and electrical repolarization abnormalities. Children who already have known congenital heart disease or a history of other heart problems will not be included in the study.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 60 (estimated)
- First submitted
- 25 Mar 2026
- Start date
- 1 Apr 2026
- Primary completion date
- 30 Apr 2027
- Lead sponsor
- Assiut University
- Diseases
- High blood pressure
- NCT number
- NCT07502196
What you commit to
- Study type: Observational
- Planned participants: 60
- From 1 Apr 2026 to the primary completion date, 30 Apr 2027
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- All patients known to have congenital heart disease or previous cardiac disease.
Who the study is looking for
- All patients below 18 years who diagnosed with chronic liver disease.
Age in the registry: - to 17 years · Sex: All
This page is information, not medical advice. Discuss any trial with your doctor.